Year |
Citation |
Score |
2016 |
Payer D, Williams B, Mansouri E, Stevanovski S, Nakajima S, Le Foll B, Kish S, Houle S, Mizrahi R, George SR, George TP, Boileau I. Corticotropin-releasing hormone and dopamine release in healthy individuals. Psychoneuroendocrinology. 76: 192-196. PMID 27951520 DOI: 10.1016/J.Psyneuen.2016.11.034 |
0.322 |
|
2016 |
Boileau I, Payer D, Rusjan PM, Houle S, Tong J, McCluskey T, Wilson AA, Kish SJ. Heightened Dopaminergic Response to Amphetamine at the D3 Dopamine Receptor in Methamphetamine Users. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 27353309 DOI: 10.1038/Npp.2016.108 |
0.37 |
|
2016 |
Okita K, Ghahremani DG, Payer DE, Robertson CL, Dean AC, Mandelkern MA, London ED. Emotion dysregulation and amygdala dopamine D2-type receptor availability in methamphetamine users. Drug and Alcohol Dependence. PMID 26880595 DOI: 10.1016/J.Drugalcdep.2016.01.029 |
0.614 |
|
2015 |
Okita K, Ghahremani DG, Payer DE, Robertson CL, Mandelkern MA, London ED. Relationship of Alexithymia Ratings to Dopamine D2-type Receptors in Anterior Cingulate and Insula of Healthy Control Subjects but not Methamphetamine-Dependent Individuals. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). PMID 26657175 DOI: 10.1093/Ijnp/Pyv129 |
0.57 |
|
2015 |
Zack M, Boileau I, Payer D, Chugani B, Lobo DS, Houle S, Wilson AA, Warsh JJ, Kish SJ. Differential cardiovascular and hypothalamic pituitary response to amphetamine in male pathological gamblers versus healthy controls. Journal of Psychopharmacology (Oxford, England). PMID 26152320 DOI: 10.1177/0269881115592338 |
0.318 |
|
2015 |
Boileau I, Nakajima S, Payer D. Imaging the D3 dopamine receptor across behavioral and drug addictions: Positron emission tomography studies with [(11)C]-(+)-PHNO. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 26141509 DOI: 10.1016/J.Euroneuro.2015.06.002 |
0.36 |
|
2015 |
Le Foll B, Payer D, Di Ciano P, Guranda M, Nakajima S, Tong J, Mansouri E, Wilson AA, Houle S, Meyer JH, Graff-Guerrero A, Boileau I. Occupancy of Dopamine D3 and D2 Receptors by Buspirone: A [(11)C]-(+)-PHNO PET Study in Humans. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 26089182 DOI: 10.1038/Npp.2015.177 |
0.348 |
|
2015 |
Payer DE, Guttman M, Kish SJ, Tong J, Strafella A, Zack M, Adams JR, Rusjan P, Houle S, Furukawa Y, Wilson AA, Boileau I. [¹¹C]-(+)-PHNO PET imaging of dopamine D(2/3) receptors in Parkinson's disease with impulse control disorders. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 160-6. PMID 25641350 DOI: 10.1002/Mds.26135 |
0.349 |
|
2015 |
Wing VC, Payer DE, Houle S, George TP, Boileau I. Measuring cigarette smoking-induced cortical dopamine release: A [¹¹C]FLB-457 PET study. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 40: 1417-27. PMID 25502631 DOI: 10.1038/Npp.2014.327 |
0.375 |
|
2015 |
Okita K, Ghahremani D, Payer D, Mandelkern M, London E. Relationship between alexithymia and dopamine D2-type receptor availability: Methamphetamine-dependent subjects differ from healthy controls Drug and Alcohol Dependence. 146: e56. DOI: 10.1016/J.Drugalcdep.2014.09.523 |
0.463 |
|
2014 |
Payer D, Balasubramaniam G, Boileau I. What is the role of the D3 receptor in addiction? A mini review of PET studies with [(11)C]-(+)-PHNO. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 52: 4-8. PMID 23999545 DOI: 10.1016/J.Pnpbp.2013.08.012 |
0.353 |
|
2014 |
Payer DE, Behzadi A, Kish SJ, Houle S, Wilson AA, Rusjan PM, Tong J, Selby P, George TP, McCluskey T, Boileau I. Heightened D3 dopamine receptor levels in cocaine dependence and contributions to the addiction behavioral phenotype: a positron emission tomography study with [11C]-+-PHNO. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 311-8. PMID 23921256 DOI: 10.1038/Npp.2013.192 |
0.342 |
|
2013 |
Boileau I, Payer D, Chugani B, Lobo D, Behzadi A, Rusjan PM, Houle S, Wilson AA, Warsh J, Kish SJ, Zack M. The D2/3 dopamine receptor in pathological gambling: a positron emission tomography study with [11C]-(+)-propyl-hexahydro-naphtho-oxazin and [11C]raclopride. Addiction (Abingdon, England). 108: 953-63. PMID 23167711 DOI: 10.1111/Add.12066 |
0.347 |
|
2012 |
Payer DE, Nurmi EL, Wilson SA, McCracken JT, London ED. Effects of methamphetamine abuse and serotonin transporter gene variants on aggression and emotion-processing neurocircuitry. Translational Psychiatry. 2: e80. PMID 22832817 DOI: 10.1038/Tp.2011.73 |
0.509 |
|
2012 |
Payer DE, Baicy K, Lieberman MD, London ED. Overlapping neural substrates between intentional and incidental down-regulation of negative emotions. Emotion (Washington, D.C.). 12: 229-35. PMID 22468617 DOI: 10.1037/a0027421 |
0.569 |
|
2012 |
Boileau I, Payer D, Houle S, Behzadi A, Rusjan PM, Tong J, Wilkins D, Selby P, George TP, Zack M, Furukawa Y, McCluskey T, Wilson AA, Kish SJ. Higher binding of the dopamine D3 receptor-preferring ligand [11C]-(+)-propyl-hexahydro-naphtho-oxazin in methamphetamine polydrug users: a positron emission tomography study. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 1353-9. PMID 22279219 DOI: 10.1523/Jneurosci.4371-11.2012 |
0.348 |
|
2011 |
Payer DE, Lieberman MD, London ED. Neural correlates of affect processing and aggression in methamphetamine dependence. Archives of General Psychiatry. 68: 271-82. PMID 21041607 DOI: 10.1001/Archgenpsychiatry.2010.154 |
0.464 |
|
2010 |
Azizian A, Nestor LJ, Payer D, Monterosso JR, Brody AL, London ED. Smoking reduces conflict-related anterior cingulate activity in abstinent cigarette smokers performing a Stroop task. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 775-82. PMID 19907418 DOI: 10.1038/Npp.2009.186 |
0.45 |
|
2009 |
Payer D, Lieberman, London E. Emotion Regulation and Aggression during Early Abstinence from Methamphetamine Neuroimage. 47. DOI: 10.1016/S1053-8119(09)70370-2 |
0.562 |
|
2009 |
Payer DE, Lieberman MD, Monterosso JR, Xu J, Fong TW, London ED. Erratum to “Differences in cortical activity between methamphetamine-dependent and healthy individuals performing a facial affect matching task” [Drug and Alcohol Dependence 93 (2008) 93–102] Drug and Alcohol Dependence. 101: 213-214. DOI: 10.1016/J.Drugalcdep.2007.09.026 |
0.478 |
|
2008 |
Payer DE, Lieberman MD, Monterosso JR, Xu J, Fong TW, London ED. Differences in cortical activity between methamphetamine-dependent and healthy individuals performing a facial affect matching task. Drug and Alcohol Dependence. 93: 93-102. PMID 17964741 DOI: 10.1016/J.Drugalcdep.2007.09.009 |
0.578 |
|
2006 |
Payer D, Marshuetz C, Sutton B, Hebrank A, Welsh RC, Park DC. Decreased neural specialization in old adults on a working memory task. Neuroreport. 17: 487-91. PMID 16543812 DOI: 10.1097/01.Wnr.0000209005.40481.31 |
0.308 |
|
Low-probability matches (unlikely to be authored by this person) |
2015 |
Payer DE, Guttman M, Kish SJ, Tong J, Adams JR, Rusjan P, Houle S, Furukawa Y, Wilson AA, Boileau I. D3 dopamine receptor-preferring [11C]PHNO PET imaging in Parkinson patients with dyskinesia. Neurology. PMID 26718579 DOI: 10.1212/Wnl.0000000000002285 |
0.295 |
|
2013 |
Clark L, Averbeck B, Payer D, Sescousse G, Winstanley CA, Xue G. Pathological choice: the neuroscience of gambling and gambling addiction. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 17617-23. PMID 24198353 DOI: 10.1523/Jneurosci.3231-13.2013 |
0.295 |
|
2012 |
Payer D, Boileau I, Zack M. Investigating dopamine function in pathological gambling with [ 11 C] Raclopride and [ 11 C]-(+)-PHNO PET F1000research. 3. DOI: 10.7490/F1000Research.1090280.1 |
0.289 |
|
2015 |
Payer D, Park MT, Kish S, Lerch J, Boileau I, Chakravarty MM. Exploring brain morphology in poly-stimulant abuse: shape, volume, and surface area abnormalities in Ecstasy-cocaine- and methamphetamine-preferring individuals Drug and Alcohol Dependence. 146: e65. DOI: 10.1016/J.Drugalcdep.2014.09.546 |
0.283 |
|
2014 |
Boileau I, Payer D, Chugani B, Lobo DS, Houle S, Wilson AA, Warsh J, Kish SJ, Zack M. In vivo evidence for greater amphetamine-induced dopamine release in pathological gambling: a positron emission tomography study with [(11)C]-(+)-PHNO. Molecular Psychiatry. 19: 1305-13. PMID 24322203 DOI: 10.1038/Mp.2013.163 |
0.27 |
|
2015 |
Payer DE, Park MT, Kish SJ, Kolla NJ, Lerch JP, Boileau I, Chakravarty MM. Personality disorder symptomatology is associated with anomalies in striatal and prefrontal morphology. Frontiers in Human Neuroscience. 9: 472. PMID 26379535 DOI: 10.3389/Fnhum.2015.00472 |
0.254 |
|
2016 |
Boileau I, Mansouri E, Williams B, Le Foll B, Rusjan P, Mizrahi R, Tyndale RF, Huestis MA, Payer DE, Wilson AA, Houle S, Kish SJ, Tong J. Fatty Acid Amide Hydrolase Binding in Brain of Cannabis Users: Imaging With the Novel Radiotracer [(11)C]CURB. Biological Psychiatry. PMID 27345297 DOI: 10.1016/J.Biopsych.2016.04.012 |
0.234 |
|
2012 |
Payer DE, Dean AC, Boileau I. What matters in measuring methamphetamine-related cognitive impairments: 'abnormality detection' versus 'everyday import'? Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 37: 1081-2. PMID 22419225 DOI: 10.1038/Npp.2011.309 |
0.223 |
|
2021 |
Biggar E, Papamihali K, Leclerc P, Hyshka E, Graham B, Taylor M, Payer D, Maloney-Hall B, Buxton JA. Towards cross-Canada monitoring of the unregulated street drug supply. Bmc Public Health. 21: 1678. PMID 34525994 DOI: 10.1186/s12889-021-11757-x |
0.078 |
|
2023 |
Fisher A, Young MM, Payer D, Pacheco K, Dubeau C, Mago V. Automating Detection of Drug-Related Harms on Social Media: Machine Learning Framework. Journal of Medical Internet Research. 25: e43630. PMID 37725410 DOI: 10.2196/43630 |
0.059 |
|
2012 |
Park DC, Payer D. Working Memory Across the Adult Lifespan Lifespan Cognition: Mechanisms of Change. DOI: 10.1093/acprof:oso/9780195169539.003.0009 |
0.01 |
|
Hide low-probability matches. |